Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease-Reference-Cited by-同舟云学术

Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease

Published:2015-02 Issue: Volume:587 Page:1-4
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

García María Concepción,Cinquina Valentina,Palomo-Garo Cristina,Rábano Alberto,Fernández-Ruiz Javier

Funder

CIBERNED

MINECO

CAM

Publisher

Elsevier BV

Subject

General Neuroscience

Reference25 articles.

1. Molecular characterization of a peripheral receptor for cannabinoids;Munro;Nature,1993

2. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids;Lynn;J. Pharmacol. Exp. Ther.,1994

3. ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance;Di Marzo;Biochim. Biophys. Acta,1998

4. Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias;Rodríguez-Cueto;Br. J. Pharmacol.,2014

5. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling;Molina-Holgado;J. Neurosci.,2002

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the cannabinoid type-2 receptor and Parkinson’s disease;Frontiers in Aging Neuroscience;2024-01-08

2. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy;Biomolecules;2023-09-14

3. Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy;2023-08-27

4. Beta-caryophyllene inhibits the permeability of the blood–brain barrier in MPTP-induced parkinsonism;Neurología;2023-08

5. Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential;Current Medicinal Chemistry;2023-04